Status:
UNKNOWN
Exocrine Pancreatic Function Testing in Cystic Fibrosis
Lead Sponsor:
Haukeland University Hospital
Collaborating Sponsors:
University of Bergen
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
15+ years
Brief Summary
Purpose The purpose of this study is to develop and validate multimodal testing of exocrine pancreatic function (EPF). The investigators will be testing exocrine pancreatic function in patients with c...
Detailed Description
Study design: Observational, cohort studies. Patient characterization: Age, gender, and Genetic status from electronical records. Exocrine function testing (EPF): Secretin stimulated ultrasound and ...
Eligibility Criteria
Inclusion
- Diagnosis cystic fibrosis. Age over 15 years. Assigned to routine control at department of lung diseases, Haukeland university hospital.
Exclusion
- Unable to concent, allergies to Sonovue ultrasound contrast, pregnant or breastfeeding, contraindications against endoscopy.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2018
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01446861
Start Date
January 1 2011
End Date
July 1 2018
Last Update
August 24 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haukeland University Hospital
Bergen, Norway, 5020